Literature DB >> 12490286

Activated protein C-dependent and -independent anticoagulant activities of protein S have different structural requirements.

Mary J Heeb1, John H Griffin.   

Abstract

Plasma protein S exhibits multiple anticoagulant activities. About 20% of protein S normally circulates in a form that is cleaved in its thrombin-sensitive region (TSR, residues 47-72) and this cleaved protein S is inactive as a cofactor for activated protein C (APC). To clarify whether the same cleavage(s) in the TSR neutralizes both APC-cofactor and APC-independent direct anticoagulant activities, protein S was treated with several proteases, and activities and cleavages were monitored. Thrombin cleaved protein S first at Arg49, which abolished protein S APC-cofactor activity, but not APC-independent activity. A slower second thrombin cleavage at Arg70 abolished the direct prothrombinase inhibitory activity of protein S and its ability to bind phospholipids. Factor Xa cleaved protein S only at Arg60 and abolished APC-cofactor activity but not APC-independent anticoagulant activity. The snake venom enzyme Protac C efficiently cleaved protein S at two sites in the TSR, which impaired both types of protein S anticoagulant activity in the presence of phospholipids. Protac C-cleaved protein S did not compete with Factor Xa for limiting phospholipid surfaces but could still inhibit prothrombinase activity in the absence of phospholipids. Thus, the APC-cofactor activity protein S is significantly more sensitive to structural changes in the TSR than is the APC-independent activity of protein S.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12490286     DOI: 10.1006/bcmd.2002.0558

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  8 in total

1.  Gly74Ser mutation in protein C causes thrombosis due to a defect in protein S-dependent anticoagulant function.

Authors:  Changming Chen; Likui Yang; Bruno O Villoutreix; Xuefeng Wang; Qiulan Ding; Alireza R Rezaie
Journal:  Thromb Haemost       Date:  2017-04-13       Impact factor: 5.249

2.  Gly197Arg mutation in protein C causes recurrent thrombosis in a heterozygous carrier.

Authors:  Yeling Lu; Hemant Giri; Bruno O Villoutreix; Qiulan Ding; Xuefeng Wang; Alireza R Rezaie
Journal:  J Thromb Haemost       Date:  2020-04-09       Impact factor: 5.824

3.  Platelet protein S directly inhibits procoagulant activity on platelets and microparticles.

Authors:  Fabian Stavenuiter; Nicole F Davis; Erning Duan; Andrew J Gale; Mary J Heeb
Journal:  Thromb Haemost       Date:  2012-12-13       Impact factor: 5.249

4.  Protein S protects neurons from excitotoxic injury by activating the TAM receptor Tyro3-phosphatidylinositol 3-kinase-Akt pathway through its sex hormone-binding globulin-like region.

Authors:  Zhihui Zhong; Yaoming Wang; Huang Guo; Abhay Sagare; José A Fernández; Robert D Bell; Theresa M Barrett; John H Griffin; Robert S Freeman; Berislav V Zlokovic
Journal:  J Neurosci       Date:  2010-11-17       Impact factor: 6.167

5.  Plasma protein S residues 37-50 mediate its binding to factor Va and inhibition of blood coagulation.

Authors:  Mary J Heeb; Rolf M Mesters; José A Fernández; Tilman M Hackeng; Ryon K Nakasone; John H Griffin
Journal:  Thromb Haemost       Date:  2013-05-23       Impact factor: 5.249

6.  Plasma protein S contains zinc essential for efficient activated protein C-independent anticoagulant activity and binding to factor Xa, but not for efficient binding to tissue factor pathway inhibitor.

Authors:  Mary J Heeb; Duane Prashun; John H Griffin; Bonno N Bouma
Journal:  FASEB J       Date:  2009-02-24       Impact factor: 5.191

7.  Activated protein C cofactor function of protein S: a critical role for Asp95 in the EGF1-like domain.

Authors:  Helena M Andersson; Márcia J Arantes; James T B Crawley; Brenda M Luken; Sinh Tran; Björn Dahlbäck; David A Lane; Suely M Rezende
Journal:  Blood       Date:  2010-03-22       Impact factor: 22.113

8.  Protein S K196E mutation reduces its cofactor activity for APC but not for TFPI.

Authors:  Keiko Maruyama; Masashi Akiyama; Toshiyuki Miyata; Koichi Kokame
Journal:  Res Pract Thromb Haemost       Date:  2018-09-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.